Parthanatos and its associated components: promising therapeutic targets for cancer

Y Zhou, L Liu, S Tao, Y Yao, Y Wang, Q Wei… - Pharmacological …, 2021 - Elsevier
Parthanatos is a PARP1-dependent, caspase-independent, cell-death pathway that is
distinct from apoptosis, necrosis, or other known forms of cell death. Parthanatos is a …

Bottom-up proteomics (2013–2015): kee** up in the era of systems biology

J Mayne, Z Ning, X Zhang, AE Starr, R Chen… - Analytical …, 2016 - ACS Publications
Over 17,000 papers related to proteomics have been published since our 2011− 2013
review. A subset are true gems reporting amazing applications of proteomics to better …

Opioid receptors signaling network

L Gopalakrishnan, O Chatterjee… - Journal of Cell …, 2022 - Wiley Online Library
Opioid receptors belong to the class AG‐protein‐coupled receptors and are activated by
alkaloid opiates such as morphine, and endogenous ligands such as endorphins and …

Emerging role of the macrophage migration inhibitory factor family of cytokines in neuroblastoma. pathogenic effectors and novel therapeutic targets?

E Cavalli, R Ciurleo, MC Petralia, P Fagone, R Bella… - Molecules, 2020 - mdpi.com
Neuroblastoma (NB) is the most frequent extracranial pediatric tumor. Despite the current
available multiple therapeutic options, the prognosis for high-risk NB patients remains …

Phosphoproteomic analysis identifies CLK1 as a novel therapeutic target in gastric cancer

N Babu, SM Pinto, M Biswas, T Subbannayya… - Gastric Cancer, 2020 - Springer
Background Phosphorylation is an important regulatory mechanism of protein activity in
cells. Studies in various cancers have reported perturbations in kinases resulting in aberrant …

The ERK/MAPK pathway is overexpressed and activated in gallbladder cancer

K Buchegger, R Silva, J López, C Ili, JC Araya… - … -Research and Practice, 2017 - Elsevier
Gallbladder cancer (GBC) is a highly fatal disease with poor prognosis and few therapeutic
alternatives. Molecular profiling has revealed that the deregulation in the ERK/MAPK …

MicroRNA-451a inhibits gemcitabine-refractory biliary tract cancer progression by suppressing the MIF-mediated PI3K/AKT pathway

T Obata, K Tsutsumi, E Ueta, T Oda, T Kikuchi… - … Therapy-Nucleic Acids, 2023 - cell.com
Gemcitabine is an effective chemotherapeutic agent for biliary tract cancers (BTCs),
including gallbladder cancer (GBC) and cholangiocarcinoma (CCA). However, few other …

MIF inhibitor, ISO-1, attenuates human pancreatic cancer cell proliferation, migration and invasion in vitro, and suppresses xenograft tumour growth in vivo

B Cheng, Q Wang, Y Song, Y Liu, Y Liu, S Yang, D Li… - Scientific Reports, 2020 - nature.com
This study sought to investigate the biological effects of specific MIF inhibitor, ISO-1, on the
proliferation, migration and invasion of PANC-1 human pancreatic cells in vitro, and on …

MIF promotes perineural invasion through EMT in salivary adenoid cystic carcinoma

M Zhang, Z Li, H Wang, S Wang, X Yu… - Molecular …, 2019 - Wiley Online Library
Macrophage migration inhibitory factor (MIF) is a prominent orchestrator during the onset
and progression of cancer. Recently, MIF was detected in salivary adenoid cystic carcinoma …

A molecular network map of orexin-orexin receptor signaling system

O Chatterjee, L Gopalakrishnan, D Pullimamidi… - Journal of Cell …, 2023 - Springer
Orexins are excitatory neuropeptides, which are predominantly associated with feeding
behavior, sleep-wake cycle and energy homeostasis. The orexinergic system comprises of …